Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aditxt Inc.
ADTXCurrent price
0.47 USD
+0.026 USD (+5.80%)
Last closed
0.44 USD
Company
www.aditxt.com
ISIN
US0070251097
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 313 396 USD
Yield for 12 month
-98.42 %
1Y
3Y
5Y
10Y
15Y
ADTX
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
61 USDP/E ratio
–Dividend Yield
–Current Year
+645 176 USD
Last Year
+933 715 USD
Current Quarter
+44 276 USD
Last Quarter
+79 680 USD
Current Year
-654 243 USD
Last Year
+166 936 USD
Current Quarter
-136 888 USD
Last Quarter
-129 884 USD
Key Figures ADTX
1 year
3 years
5 years
10 years
EBITDA
-33 094 198 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-117.61 %
PEG Ratio
–
Return On Equity TTM
-3493.63 %
Wall Street Target Price
61 USD
Revenue TTM
329 739 USD
Book Value
3.29 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-80 %
Dividend Yield
–
Gross Profit TTM
166 936 USD
Earnings per share
-34.38 USD
Diluted Eps TTM
-34.38 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ADTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ADTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:40
Payout Ratio
–
Last Split Date
18.08.2023
Dividend Date
–
Stock Valuation ADTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.3707
Enterprise Value Revenue
30.4577
Price Sales TTM
7.0158
Enterprise Value EBITDA
0.0225
Price Book MRQ
0.3414
Financials ADTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ADTX
For 52 weeks
0.56 USD
43.75 USD
50 Day MA
1.28 USD
Shares Short Prior Month
399 435
200 Day MA
2.85 USD
Short Ratio
0.11
Shares Short
672 774
Short Percent
20.59 %
BeatStart